Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 7, 2009, Pages 3432-3437

  Wolf Schnurrbusch, Ute E K ^a   Ceklic, Lala ^a,b   Brinkmann, Christian K ^a   Iliev, Milko E ^a   Frey, Manuel ^a   Rothenbuehler, Simon P ^a   Enzmann, Volker ^a   Wolf, Sebastian ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Klinicki Centar Isotocno Sarajevo ^*  (Bosnia and Herzegovina)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; EYE PHOTOGRAPHY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; NORMAL HUMAN; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; REPRODUCIBILITY; RETINA MACULA LUTEA; TEST RETEST RELIABILITY; THICKNESS; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION; VOLUNTEER; ANATOMY; COMPARATIVE STUDY; HISTOLOGY; INSTRUMENTATION; MIDDLE AGED; MORPHOMETRICS; RETINA; STANDARD;

ADULT; ANATOMY, CROSS-SECTIONAL; BODY WEIGHTS AND MEASURES; FEMALE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETINA; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 67649946247     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2970     Document Type: Article

References (27)

1. Hee MR, Puliafito C, Carlton W, et al. Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol. 1995;113(8):1019-1029.
2. Hee MR, Puliafito CA, Wong C, et al. Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol. 1995;113(8):1019-1029.
3. Puliafito CA, Hee MR, Lin CP, et al. Imaging of macular diseases with optical coherence tomography. Ophthalmology. 1995;102: 217-229.
4. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254(5035):1178-1181.
5. Barbazetto I, Burdan A, Bressler NM, et al. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment. TAP and VIP report No. 2. Arch Ophthalmol. 2003;121(9):1253-1268.
6. Hee MR. Artifacts in optical coherence tomography topographic maps. Am J Ophthalmol. 2005;139(1):154-155.
7. Massin P, Vicaut E, Haouchine B, Erginay A, Paques M, Gaudric A. Reproducibility of retinal mapping using optical coherence tomography. Arch Ophthalmol. 2001;119(8):1135-1142.
8. Toth CA, Narayan DG, Boppart SA, et al. A comparison of retinal morphology viewed by optical coherence tomography and by light microscopy. Arch Ophthalmol. 1997;115(11):1425-1428.
9. Chauhan DS, Marshall J. The interpretation of optical coherence tomography images of the retina. Invest Ophthalmol Vis Sci. 1999; 40(10):2332-2342.
10. Hee MR, Puliafito CA, Duker JS, et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology. 1998;105(2):360-370.
11. Massin P, Erginay A, Haouchine B, Mehidi AB, Paques M, Gaudric A. Retinal thickness in healthy and diabetic subjects measured using optical coherence tomography mapping software. Eur J Ophthalmol. 2002;12(2):102-108.
12. Pieramici DJ, Avery RL. Ranibizumab: treatment in patients with neovascular age-related macular degeneration. Expert Opin Biol Ther. 2006;6(11):1237-1245.
13. Midena E, Segato T, Bottin G, Piermarocchi S, Fregona I. The effect on the macular function of laser photocoagulation for diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 1992;230(2):162-165.
14. Regillo CD, Brown DM, Abraham P, et al. Randomized, doublemasked, sham-controlled trial of ranibizumab for neovascular agerelated macular degeneration: PIER Study Year 1. Am J Ophthalmol 2008;145(2):239-248-e235.
15. Ruggeri M, Wehbe H, Jiao S, et al. In vivo three-dimensional high-resolution imaging of rodent retina with spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2007; 48(4):1808-1814.
16. Wojtkowski M, Srinivasan V, Fujimoto JG, et al. Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology. 2005;112(10):1734-1746.
17. Brinkmann CK, Wolf S, Wolf-Schnurrbusch UE. Multimodal imaging in macular diagnostics: combined OCT-SLO improves thera-peutical monitoring. Graefes Arch Clin Exp Ophthalmol. 2008; 246(1):9-16.
18. Drexler W, Sattmann H, Hermann B, et al. Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography. Arch Ophthalmol. 2003;121(5):695-706.
19. Holm S. A simple sequentially rejective multiple test procedure. Scand J Statist. 1999;6:65-70.
20. Wolf S, Arend O, Reim M. Measurement of retinal hemodynamics with scanning laser ophthalmoscopy: reference values and variation. Surv Ophthalmol. 1994;38(Suppl):95-100.
21. Muscat S, Parks S, Kemp E, Keating D. Repeatability and reproducibility of macular thickness measurements with the Humphrey OCT system. Invest Ophthalmol Vis Sci. 2002;43(2):490-495.
22. Koozekanani D, Roberts C, Katz SE, Herderick EE. Intersession repeatability of macular thickness measurements with the Humphrey 2000 OCT. Invest Ophthalmol Vis Sci. 2000;41(6):1486-1491.
23. Gürses-Ozden R, Teng C, Vessani R, Zafar S, Liebmann JM, Ritch R. Macular and retinal nerve fiber layer thickness measurement reproducibility using optical coherence tomography (OCT-3). J Glaucoma. 2004;13(3):238-244.
24. Polito A, Del Borrello M, Polini G, Furlan F, Isola M, Bandello F. Diurnal variation in clinically significant diabetic macular edema measured by the Stratus OCT. Retina. 2006;26(1):14-20.
25. Forooghian F, Cukras C, Meyerle CB, Chew EY, Wong WT. Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema. Invest Ophthalmol Vis Sci. 2008;49(10):4290-4296.
26. Leung CK, Cheung CY, Weinreb RN, et al. Comparison of macular thickness measurements between time domain and spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2008;49(11):4893-4897.
27. Wolf-Schnurrbusch UE, Enzmann V, Brinkmann CK, Wolf S. Morphologic changes in patients with geographic atrophy assessed with a novel spectral OCT-SLO combination. Invest Ophthalmol Vis Sci. 2008;49(7):3095-3099.